Puma Biotechnology Inc (PBYI)
4.83
-0.30
(-5.85%)
USD |
NASDAQ |
Apr 24, 16:00
4.835
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Cash from Financing (TTM): 0.00 for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 2.431M |
June 30, 2023 | 2.378M |
March 31, 2023 | 2.378M |
December 31, 2022 | 12.22M |
September 30, 2022 | 9.79M |
June 30, 2022 | -22.09M |
March 31, 2022 | -22.09M |
December 31, 2021 | -31.93M |
September 30, 2021 | -41.91M |
June 30, 2021 | -9.934M |
March 31, 2021 | -9.932M |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | -67.07M |
September 30, 2019 | -36.57M |
June 30, 2019 | -35.64M |
March 31, 2019 | 106.39M |
December 31, 2018 | 108.45M |
September 30, 2018 | 139.07M |
June 30, 2018 | 147.79M |
March 31, 2018 | 77.55M |
December 31, 2017 | 75.11M |
Date | Value |
---|---|
September 30, 2017 | 176.08M |
June 30, 2017 | 166.48M |
March 31, 2017 | 162.91M |
December 31, 2016 | 162.43M |
September 30, 2016 | 1.671M |
June 30, 2016 | 6.916M |
March 31, 2016 | 13.95M |
December 31, 2015 | 233.36M |
September 30, 2015 | 238.57M |
June 30, 2015 | 233.20M |
March 31, 2015 | 226.17M |
December 31, 2014 | 135.97M |
September 30, 2014 | 131.51M |
June 30, 2014 | 131.66M |
March 31, 2014 | 131.66M |
December 31, 2013 | 2.215M |
September 30, 2013 | 129.40M |
June 30, 2013 | 129.26M |
March 31, 2013 | 129.26M |
December 31, 2012 | 129.26M |
September 30, 2012 | 56.74M |
June 30, 2012 | 56.91M |
March 31, 2012 | 56.95M |
December 31, 2011 | 56.95M |
September 30, 2011 | 0.2067M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-67.07M
Minimum
Dec 2019
12.22M
Maximum
Dec 2022
-16.53M
Average
-9.934M
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
ADMA Biologics Inc | -38.99M |
Regeneron Pharmaceuticals Inc | -1.790B |
Sarepta Therapeutics Inc | 125.00M |
CytomX Therapeutics Inc | 30.23M |
Mirum Pharmaceuticals Inc | 336.60M |